1. United States Stocks

  2. •

    Health technology

  3. •

    Biotechnology
Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

109.90
EUR
-1.85
(-1.66%)
2.99EPS
22.08P/E
7.75BMarket Cap
Nov 09Next Earn

No stock splits recorded

Our records contain no stock splits for Halozyme Therapeutics, Inc. (FRA:RV7).

Stock splits API